X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
melanoma (8) 8
index medicus (7) 7
humans (6) 6
oncology (5) 5
targeted therapy (5) 5
metastatic melanoma (4) 4
survival (4) 4
cancer (3) 3
drug resistance, neoplasm (3) 3
immunotherapy (3) 3
melanoma - drug therapy (3) 3
mutations (3) 3
pharmacology & pharmacy (3) 3
animals (2) 2
antineoplastic agents - therapeutic use (2) 2
article (2) 2
braf (2) 2
clinical trials as topic (2) 2
ctla-4 blockade (2) 2
cutaneous melanoma (2) 2
drug interactions (2) 2
hematology, oncology and palliative medicine (2) 2
immune checkpoint (2) 2
immune checkpoint blockade (2) 2
inhibition (2) 2
melanoma - immunology (2) 2
open-label (2) 2
pd-1 blockade (2) 2
programmed cell death 1 receptor - antagonists & inhibitors (2) 2
proto-oncogene proteins b-raf - antagonists & inhibitors (2) 2
resistance (2) 2
therapy (2) 2
vemurafenib (2) 2
aberrations (1) 1
abundance (1) 1
adjuvant (1) 1
adjuvant dabrafenib (1) 1
adult (1) 1
aged (1) 1
anilides - adverse effects (1) 1
anilides - pharmacokinetics (1) 1
anilides - therapeutic use (1) 1
animal models (1) 1
anti-ctla-4 (1) 1
anti-pd-1 (1) 1
antibiotics (1) 1
antibodies, monoclonal - pharmacology (1) 1
antineoplastic agents - adverse effects (1) 1
antineoplastic agents - pharmacokinetics (1) 1
antineoplastic agents - pharmacology (1) 1
antineoplastic agents, immunological - pharmacology (1) 1
antineoplastic agents, immunological - therapeutic use (1) 1
apoptosis (1) 1
assay (1) 1
azd 4877 (1) 1
b7-h1 antigen - antagonists & inhibitors (1) 1
bacteria (1) 1
basal cell carcinoma (1) 1
basal cell nevus syndrome (1) 1
bevacizumab (1) 1
bevacizumab - pharmacology (1) 1
bevacizumab - therapeutic use (1) 1
biomarkers (1) 1
biopsy (1) 1
brain metastases (1) 1
brain neoplasms - radiotherapy (1) 1
brain neoplasms - secondary (1) 1
breast-cancer (1) 1
cancer-immunotherapy (1) 1
carcinoma, basal cell - drug therapy (1) 1
carcinoma, basal cell - metabolism (1) 1
care and treatment (1) 1
cd8 (1) 1
cell death (1) 1
cell receptors (1) 1
cell transplantation (1) 1
cell-free dna (1) 1
chemical and pharmacologic phenomena (1) 1
chemotherapy (1) 1
circulating tumor dna (1) 1
clinical-response (1) 1
clinical-trials (1) 1
cluster analysis (1) 1
combination therapy (1) 1
complete response (1) 1
cooperative-oncology-group (1) 1
ctla-4 antigen - antagonists & inhibitors (1) 1
customer relations (1) 1
cyclopamine (1) 1
dabrafenib (1) 1
dabrafenib plus trametinib (1) 1
dermatology (1) 1
diagnosis (1) 1
dietary supplements (1) 1
double-blind (1) 1
drosophila (1) 1
editor's choice (1) 1
endothelial growth-factor (1) 1
evidence-based medicine (1) 1
fecal microbiota transplantation (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Science, ISSN 0036-8075, 01/2018, Volume 359, Issue 6371, pp. 97 - 103
Journal Article
Annals of Oncology, ISSN 0923-7534, 06/2018, Volume 29, Issue 6, pp. 1445 - 1453
Abstract Background Targeted methylation sequencing of plasma cell-free DNA (cfDNA) has a potential to expand liquid biopsies to patients with tumors without... 
Cell-free DNA | Plasma | Liquid biopsy | Next-generation sequencing | Methylation | Cancer | SURVIVAL | next-generation secuencing | ASSAY | MARKERS | GENOME | CIRCULATING TUMOR DNA | ONCOLOGY | methylation | cell-free DNA | cancer | plasma | ABERRATIONS | liquid biopsy | Original articles | next-generation sequencing
Journal Article
Annals of Oncology, ISSN 0923-7534, 08/2018, Volume 29, Issue 8, pp. 1861 - 1868
Abstract Background Clinical trials have recently evaluated safety and efficacy of neoadjuvant therapy among patients with surgically resectable regional... 
Neoadjuvant therapy | Pathology | Immune checkpoint blockade | Targeted therapy | Melanoma | SURVIVAL | targeted therapy | pathology | TRAMETINIB | ADJUVANT DABRAFENIB | COMPLETE RESPONSE | melanoma | STAGE-III | neoadjuvant therapy | CHEMOTHERAPY | BREAST-CANCER | ONCOLOGY | RECOMMENDATIONS | CLINICAL-TRIALS | STANDARD | immune checkpoint blockade | Editor's Choice | Original
Journal Article
Mental Health Aspects of Developmental Disabilities, ISSN 1057-3291, 2001, Volume 4, Issue 4, pp. 143 - 147
Journal Article
Cancer Discovery, ISSN 2159-8274, 08/2016, Volume 6, Issue 8, pp. 827 - 837
Journal Article
Cancer Treatment Reviews, ISSN 0305-7372, 11/2018, Volume 70, pp. 144 - 153
Stage III melanoma encompasses a range of disease burdens, including microscopic foci of metastatic melanoma in a sentinel lymph node; bulky, clinically... 
Neoadjuvant | Adjuvant | Targeted therapy | Immunotherapy | Melanoma | STAGE-III MELANOMA | OPEN-LABEL | RADIATION-THERAPY | METASTATIC MELANOMA | DABRAFENIB PLUS TRAMETINIB | ONCOLOGY | HIGH-DOSE INTERFERON-ALPHA-2B | CUTANEOUS MELANOMA | DOUBLE-BLIND | PEGYLATED INTERFERON-ALPHA-2B | COOPERATIVE-ONCOLOGY-GROUP | Metastasis | Index Medicus
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.